Comparison results
Results: Differences Similar | ✘Acute thrombophlebitis | ✘Hypercoagulation syndrome | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 100% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
phlebitis | 96% | — | |||||||
chronic condition | — | 97% | |||||||
venous thrombosis | 82% | — | |||||||
little lupus anticoagulant | — | 96% | |||||||
veins bloating | 73% | — | |||||||
plasminogen reduced | — | 96% | |||||||
deep vein thrombosis | 69% | — | |||||||
platelet aggregation increased | — | 76% | |||||||
thrombosis with varicose | 66% | — | |||||||
prothrombin index increased | — | 64% | |||||||
veins swelling on the legs | 66% | — | |||||||
thrombocytopenia | — | 58% | |||||||
varicose veins of the legs | 49% | — | |||||||
aplastic anemia | — | 55% | |||||||
superficial veins | 47% | — | |||||||
acute leukemia | — | 54% | |||||||
venous bleeding | 46% | — | |||||||
plaques in the arteries | — | 53% | |||||||
lung infarction | 44% | — | |||||||
systemic vasculitis | — | 52% | |||||||
pain in the veins | 43% | — | |||||||
head severe | — | 50% | |||||||
vascular sclerosis | 42% | — | |||||||
thrombocytosis | — | 50% | |||||||
venous congestion | 42% | — | |||||||
nose thrombophilia | — | 49% | |||||||
thrombosis | 79% | 36% | |||||||
immunoglobulin a deficiency | — | 49% | |||||||
effects of shock | 41% | — | |||||||
neuroses in children | — | 48% | |||||||
shock states of various genesis | 40% | — | |||||||
anemia, unspecified | — | 48% | |||||||
bleeding | 39% | — | |||||||
dic syndrome | — | 48% | |||||||
up circulatory disorders | 34% | — | |||||||
feeling of blood loss | — | 48% | |||||||
high temperature | 33% | — | |||||||
coagulopathy | — | 46% | |||||||
impaired lung function | 33% | — | |||||||
vasculitis | — | 45% | |||||||
consequences of infection | 32% | — | |||||||
lymphocytic | — | 45% | |||||||
consequences of taking medications | 31% | — | |||||||
erythrocytosis | — | 45% | |||||||
migrating thrombophlebitis | 29% | — | |||||||
leukemia | — | 45% | |||||||
lymphosarcoma | — | 41% | |||||||
atherosclerosis of blood vessels | — | 41% | |||||||
neurosis | — | 40% | |||||||
traumatic illness | — | 40% | |||||||
underdevelopment | — | 39% | |||||||
protein c deficiency | — | 39% | |||||||
vascular damage | — | 38% | |||||||
with anemia | — | 37% | |||||||
changes in the blood | — | 37% | |||||||
consequences of injuries | — | 36% | |||||||
surgical infections | — | 36% | |||||||
quickly gets tired | — | 36% | |||||||
cancer | — | 35% | |||||||
weakness | — | 33% | |||||||
there are no complaints | — | 33% | |||||||
injury | — | 33% | |||||||
oncology | — | 33% | |||||||
sepsis | 37% | 38% | |||||||
bacteremia | 38% | 39% | |||||||
hemorrhagic diathesis | 38% | 39% | |||||||
bleeding | 34% | 35% | |||||||
blood diseases | 31% | 32% |
Instructions
Video
|